Treatment with angiotensin-converting enzyme (ACE) inhibitors/ angiotensin II receptor blockers (ARBs) (p = 0.14), statins (p = 0.35), and antiplatelet/anticoagulant agents (p = 0.46) was similar between DKD and non-DKD groups. This evidence concerns the gene ACE and diabetic kidney disease.